| scholarly article | Q13442814 |
| P50 | author | José Antonio García Erce | Q37840830 |
| P2093 | author name string | Manuel Muñoz | |
| Enrique Naveira | |||
| Jorge Cuenca | |||
| Elvira Bisbe | |||
| AWGE (Spanish Anaemia Working Group) | |||
| P2860 | cites work | Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal | Q23923870 |
| The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? | Q24685741 | ||
| A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications | Q28307966 | ||
| Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data | Q30985621 | ||
| Iron status and iron supplementation in peritoneal dialysis patients | Q33543055 | ||
| A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial | Q34010689 | ||
| The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate | Q34113833 | ||
| Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. | Q34399172 | ||
| Iron and immunity: a double-edged sword. | Q34557043 | ||
| Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states | Q35103840 | ||
| Parenteral iron therapy options | Q35758858 | ||
| Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. | Q35894993 | ||
| Labile iron: manifestations and clinical implications | Q35976907 | ||
| Safety of intravenous iron in clinical practice: implications for anemia management protocols | Q35976913 | ||
| Diagnosis and management of iron-deficiency anaemia | Q36057932 | ||
| Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. | Q36118510 | ||
| Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. | Q37028212 | ||
| Identification and treatment of anaemia in patients awaiting hip replacement | Q37108344 | ||
| Perioperative anaemia management: consensus statement on the role of intravenous iron. | Q37121303 | ||
| Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease | Q37162713 | ||
| Anemia and patient blood management in hip and knee surgery: a systematic review of the literature | Q37770884 | ||
| Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis | Q37822995 | ||
| Disorders of iron metabolism. Part II: iron deficiency and iron overload | Q37822997 | ||
| Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery | Q40204200 | ||
| Serious hazards of transfusion: a decade of hemovigilance in the UK. | Q40284077 | ||
| Utility of point-of-care haemoglobin measurement in the HemoCue-B haemoglobin for the initial diagnosis of anaemia | Q43320300 | ||
| Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study | Q44409303 | ||
| Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions | Q44477912 | ||
| Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin | Q44797776 | ||
| Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly | Q45063564 | ||
| Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial | Q45169824 | ||
| Update on adverse drug events associated with parenteral iron | Q46212164 | ||
| High-molecular weight iron dextran: a wolf in sheep's clothing? | Q47240364 | ||
| A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture | Q47855627 | ||
| Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement | Q47901849 | ||
| The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery | Q47955853 | ||
| Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe | Q48008699 | ||
| Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study | Q48448697 | ||
| Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty | Q48728443 | ||
| Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia | Q48739235 | ||
| Anemia management in chronic kidney disease: intravenous iron steps forward | Q48860623 | ||
| Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. | Q50569936 | ||
| Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures. | Q50705328 | ||
| Blood conservation in hip trauma. | Q51479240 | ||
| Reticulocyte hemoglobin measurement--comparison of two methods in the diagnosis of iron-restricted erythropoiesis. | Q51962040 | ||
| Proposal of an algorithm to help the choice of the best transfusion strategy. | Q52315316 | ||
| [Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents]. | Q52866630 | ||
| Iron supplementation after femoral head replacement for patients with normal iron stores. | Q52874079 | ||
| Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study | Q56785608 | ||
| [Intravenous iron-dextran: therapeutic and experimental possibilities] | Q71417912 | ||
| [Predictive factors for transfusion requirements in patients over 65 years old with subcapital hip fracture] | Q73047472 | ||
| Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial | Q73260471 | ||
| Iron pre-load for major joint replacement | Q74339256 | ||
| Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency | Q74380632 | ||
| [Preoperative hemoglobin as the only predictive factor of transfusional needs in knee arthroplasty] | Q74747598 | ||
| Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo | Q75430247 | ||
| Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors | Q77679550 | ||
| Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement | Q79359179 | ||
| Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery | Q79889321 | ||
| Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement | Q80193409 | ||
| Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery | Q80339649 | ||
| Pre-operative predictors of the requirement for blood transfusion following total hip replacement | Q80783686 | ||
| Clinical utility of the new Sysmex XE 2100 parameter - reticulocyte hemoglobin equivalent - in the diagnosis of anemia | Q81002208 | ||
| Structure, chemistry, and pharmacokinetics of intravenous iron agents | Q81110731 | ||
| The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty | Q81451909 | ||
| Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST) | Q81745351 | ||
| Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients | Q82743032 | ||
| Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study | Q83175609 | ||
| [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients] | Q83433531 | ||
| Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment | Q83982939 | ||
| Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial | Q84067773 | ||
| Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients | Q85088840 | ||
| Parenteral Iron and Recombinant Human Erythropoietin Therapy to Stimulate Erythropoiesis in Patients Undergoing Repair of Hip Fracture | Q87878296 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 8-22 | |
| P577 | publication date | 2011-11-30 | |
| P1433 | published in | Blood transfusion = Trasfusione del sangue | Q26842792 |
| P1476 | title | On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery | |
| P478 | volume | 10 |
| Q51133214 | An analysis of postoperative hemoglobin levels in patients with a fractured neck of femur. |
| Q28080101 | Blood Management Strategies in Total Knee Arthroplasty |
| Q92723432 | Blood management in fast-track orthopedic surgery: an evidence-based narrative review |
| Q37588936 | Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study |
| Q41547046 | Current misconceptions in diagnosis and management of iron deficiency |
| Q42508146 | Double bull's eye for post-operative intravenous iron in patient blood management: better outcome and cost-effective |
| Q28085514 | Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials |
| Q94325686 | Erythropoietin with iron supplementation for preoperative anaemia in non‐cardiac surgery |
| Q37555228 | Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty |
| Q55287039 | Implementation of a patient blood management program in an Australian private hospital orthopedic unit. |
| Q34718581 | Intraoperative cell salvage in revision hip surgery |
| Q42664117 | Intravenous iron supplementation with intra-articular administration of tranexamic acid reduces the rate of allogeneic transfusions after simultaneous bilateral total knee arthroplasty |
| Q43056217 | Iron therapy: a piece in the puzzle of allogeneic blood saving strategies with a relevant role in patients' blood management |
| Q33781089 | Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus |
| Q33852504 | Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain |
| Q48504728 | Perioperative Blood Management Strategies for Total Knee Arthroplasty |
| Q93047963 | Preoperative Iron Supplementation and Restrictive Transfusion Strategy in Hip Fracture Surgery |
| Q90102566 | Preparing the femur before the acetabulum does not reduce total blood loss in primary total hip replacement |
| Q36515685 | Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. |
| Q90723848 | The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial |
| Q39850254 | The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures |
| Q36757754 | The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients |
Search more.